TREACE MEDICAL CONCEPTS, INC. TMCI
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-04-23
TREACE MEDICAL CONCEPTS, INC. statistics & valuation
Market cap$289.3M
P / S1.4×
P / B3.3×
Net margin-27.7%
Return on equity-67.6%
FCF margin-13.9%
Net debt$44.9M
Enterprise value USD$334.2M
Earnings yield EBIT/EV-16.2%
Return on capital-33.9%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 79.8% | 80.4% | 81.2% | 82.0% | 82.1% | 78.3% |
| Operating margin | -25.5% | -26.6% | -27.5% | -24.6% | -17.5% | 1.5% |
| Net margin | -27.7% | -26.6% | -26.5% | -30.2% | -21.8% | -6.4% |
| FCF margin | -13.9% | -23.3% | -24.6% | -32.1% | -21.1% | -9.7% |
| Return on assets | -31.0% | -25.7% | -19.7% | -26.9% | -14.6% | -8.8% |
| Return on equity | -67.6% | -49.4% | -35.9% | -70.7% | -22.1% | -472.7% |
| Debt / equity | 0.64× | 0.47× | 0.38× | 0.87× | 0.32× | 39.92× |
| Current ratio | 4.31 | 4.62 | 4.40 | 4.41 | 7.58 | 3.53 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.